Lymphoma_Doc Profile Banner
Jason Westin, MD FACP FASCO Profile
Jason Westin, MD FACP FASCO

@Lymphoma_Doc

Followers
7K
Following
7K
Statuses
8K

Professor @MDAndersonNews, Lead of Lymphoma/Myeloma Service Line, Director of Clinical Research, Section Chief of Aggressive/Indolent Lymphomas, Opinions mine

Houston, TX
Joined January 2013
Don't wanna be here? Send us removal request.
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
10 months
I am so honored to receive the @ASCO Advocate of the Year award. Engaging with advocacy is such an important way to support our patients. #ASCOAdvocacySummit
@ASCO
ASCO
10 months
“If we're not advocating…fighting against #drugshortages & for NCI funding & the CONNECT for Health Act, others are advocating the other direction...What you're doing here really matters,” Advocate of the Year @lymphoma_doc. Congrats! #ASCOAdvocacySummit
Tweet media one
21
14
191
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
5 days
@timfenske As the same goes, you weren’t born here, but you got here as fast as you could
0
0
2
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
5 days
This will slow the search for new ways to fight cancer, and will cause deep cuts in research efforts. Other nations will take advantage of this terrible decision if 🇺🇸research falters.
@NIH
NIH
6 days
Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above what many major foundations allow and much lower than the 60%+ that some institutions charge the government today. This change will save more than $4B a year effective immediately.
Tweet media one
3
4
15
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
7 days
Congrats to all the new #FASCO recipients. This award represents years of dedication, volunteer service, and commitment to help @ASCO achieve the mission to help our patients.
@ASCO
ASCO
7 days
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more:
Tweet media one
3
3
45
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
RT @OncBrothers: This is the table we’ve used (indication, common AEs, and black📦warnings) for approved #CART THERAPY w/ @Lymphoma_Doc & @S
0
19
0
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
RT @OncBrothers: #ToxCheck: CART is approved for multiple heme malignancies. Join @SurbhiSidanaMD & @Lymphoma_Doc as we discuss key AEs & m…
0
12
0
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
RT @doctorpemm: Congratulations to Dr Nishin Bhadkamkar for being awarded the prestigious Gerald P Bodey Award for excellence in Education…
0
7
0
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
0
0
3
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
0
0
1
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
Congrats to @EMittendorfMD, @SoniSmithMD, @n8pennell, Dr. Dillmon, @ErikaHamilton9, @DrRanaMcKay, and @SuzanneColeMD! I'm honored to have been nominated, and deeply appreciate the support. I look forward to working with @ASCO leaders to move the society forward and serve our patients!
@ASCO
ASCO
2 months
Congratulations to Dr. Elizabeth A. Mittendorf on being elected to serve as ASCO President for the 2026-2027 term! Six additional members were elected to positions on the ASCO Board of Directors & Nominating Committee. Read more >
Tweet media one
2
8
59
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
RT @ASCO: Exciting news! We are officially on @BlueSky! Follow our page to stay updated on the latest news, education, events, and advancem…
0
1
0
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
RT @drsairahahmed: Fantastic presentation at the #MDAservicelineretreat by the LM team @Lymphoma_Doc Misha Hawkins, Krista Moore, Amira Pug…
0
1
0
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
RT @ASCO: Urge your Members of Congress to pass H.R. 8702/S.4532 the #SeniorsAct this year to help #Fixpriorauth Act now:
0
7
0
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
@ASCOPres @vishsath This is an incredible effort to bring the best possible cancer care to patients all over the world. Congrats to Dr @vishsath for your leadership here, and thank you, @ASCOPres for sharing this important work.
1
0
3
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
RT @ASCOPres: In my next President’s Corner interview, I speak w/ Dr. @vishsath who is bringing together an array of international experts…
0
5
0
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
RT @ASCO: The #DrugShortages crisis is a prevailing issue and is still plaguing patients with cancer, especially when it comes to IV fluid…
0
1
0
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
0
0
3
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
Don’t miss: Dr. Kunhwa Kim is presenting our trial of Axi-cel and Glofitamab for patients with refractory/relapsed large b-cell lymphoma tonight at #ASH24. This exciting combination will study two of the most potent treatments together to help more 2L patients. #lymsm
Tweet media one
0
6
32
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
Very proud of @EEdelmanSaulMD’s work highlighted in #ASH24 poster session tonight. Late relapse of aggressive lymphoma has favorable outcomes when treated again with first line therapy. #lymsm
Tweet media one
3
8
54
@Lymphoma_Doc
Jason Westin, MD FACP FASCO
2 months
RT @VincentRK: Just out: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma #ASH24 @thanosdimop @NEJM Daratumumab…
0
127
0